Pfizer has been given more time to sell its anti-cholesterol treatment Lipitor exclusively in Europe as a quid pro quo …

Sanofi has sold its Canadian dermatology unit Dermik for $425 million in order to concentrate on key growth areas like …

Idea Pharma has two new additions to its team, appointing Louisa Roberts and Ralph Torbay. Louise joins the phase II …
Novartis’ novel cancer drug Votubia has reduced the size of SEGA brain tumours in a late-stage trial. Votubia (or everolimus …
Kantar Health Names Werner Guminski CEO, Commercial StrategyNEW YORK, July 8, 2011—Kantar Health, a leading healthcare-focused global consultancy and marketing …
London-based healthcare communications agency Publicis Life Brands Resolute has boosted its Creative and Digital division with four new appointments. They …
Ferring Pharmaceuticals has moved its UK operations from Slough to new facilities just outside London in West Drayton. The Swiss …
German healthcare spending cuts have gone too far and risk jeopardising pharmaceutical innovation in the country, according to Lilly’s chief …

Pfizer has given its strongest signal yet that its animal health and nutrition arms do not have long to last …
Eurocom Healthcare Communications has been appointed to develop a strategic marketing communications programme for a UK healthcare services company. Malling …

Sanofi’s oncology franchise director Neale Harris talks to Pharmafocus about how his field is changing and offers some advice for …
Most senior managers find their executive team difficult. ‘Dysfunctional’ is a favourite word. Testing dynamics, political agendas, big personalities, strong …
Bristol-Myers Squibb has signed a $465 million deal for the rights to a potential first-in-class treatment for cancer. IPH2102 is …
Genticel has named Dr Didier Hoch, former president of Sanofi-Pasteur MSD, to its supervisory board as conseil de surveillance.Dr Hoch …

Sanofi has launched its promising advanced prostate cancer drug Jevtana in the UK following EMA approval in March. Jevtana (cabazitaxel) …

GlaxoSmithKline has revealed a new way of assessing its US sales representatives’ performance in a bid to make the manufacturer’s …

Sanofi has signed a research collaboration with Rib-X Pharmaceuticals to investigate new types of antibiotics. The French pharma company has …
Quintiles helps fund Alzheimer’s drug programme, Toxikon starts building a new facility, plus updates from Jubilant, CIToxLAB and PupPharma. Quintiles …

Pfizer has been drawn into a war of words over its smoking cessation drug Champix after a review of existing …

Bayer’s use of Twitter has caused the first social media breach of the ABPI Code of Practice. Code regulator the …